Return on equity of Retrophin, Inc.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. The company's product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc (RE-034), a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.
|BOH Bank of Hawaii Corporation||NYSE > Finance > Major Banks||2.93|
|BLD TopBuild Corp.||NYSE > Basic Industries > Engineering & Construction||2.93|
|BREW Craft Brew Alliance, Inc.||NASDAQ > Consumer Non-Durables > Beverages (Production/Distribution)||2.93|
|CSSE Chicken Soup for the Soul Entertainment, Inc.||NASDAQ > Consumer Services > Movies/Entertainment||2.93|
|FNV Franco-Nevada Corporation||NYSE > Basic Industries > Precious Metals||2.93|
|ACXM Acxiom Corporation||NASDAQ > Technology > EDP Services||2.93|
|RTRX Retrophin, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||2.93|
|BRACU Black Ridge Acquisition Corp.||NASDAQ > Finance > Business Services||1,482.86|
|VNCE Vince Holding Corp.||NYSE > Consumer Services > Clothing/Shoe/Accessory Stores||1,676.00|
|ANTH Anthera Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||1,690.00|
|W Wayfair Inc.||NYSE > Consumer Services > Catalog/Specialty Distribution||2,786.29|
|HYAC Haymaker Acquisition Corp.||NASDAQ||3,183.33|
|CMSS CM Seven Star Acquisition Corporation||NASDAQ > Finance > Business Services||4,865.00|